Skip to main content

What the FDA labels say about taking them together

Daratumumab and pomalidomide

Daratumumab's FDA label of September 8, 2026 names pomalidomide in its warnings and precautions section; the pomalidomide label PlainMeds reads does not name daratumumab. The daratumumab label: “The combination of DARZALEX with lenalidomide, pomalidomide, or thalidomide is contraindicated in pregnant women, because lenalidomide, pomalidomide, and thalidomide may cause birth defects and death of the unborn child.”

Check it at the source: the daratumumab FDA label on DailyMed (effective September 8, 2026, Janssen Biotech, Inc.); the pomalidomide FDA label on DailyMed (effective February 26, 2025, Celgene Corporation).

What does the daratumumab label say about pomalidomide?

Daratumumab label, warnings and precautions

The combination of DARZALEX with lenalidomide, pomalidomide, or thalidomide is contraindicated in pregnant women, because lenalidomide, pomalidomide, and thalidomide may cause birth defects and death of the unborn child.

Source: FDA drug label (Darzalex IV), Janssen Biotech, Inc., effective September 8, 2026 (SPL set a4d0efe9-5e54-467e-9eb4-56fa7d53b60b), via openFDA; the full label on DailyMed

What does the pomalidomide label say about daratumumab?

Pomalidomide's label (effective February 26, 2025) does not name daratumumab in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Pomalyst), NDA204026 (Bristol), as published by Celgene Corporation, effective February 26, 2025 (SPL set 2b25ef01-5c9e-11e1-b86c-0800200c9a66), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Daratumumab generic labelers
11Pomalidomide generic labelers
DaratumumabPomalidomide
Labeled forLeukemia, lymphoma and myelomaLeukemia, lymphoma and myeloma
Boxed warningNoYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?